Clinical and genetic analyses of patients with lateralized overgrowth

  • Kim, Yoon-Myung; 
  • Lee, Yena; 
  • Choi, Yunha; 
  • Choi, In Hee; 
  • Heo, Sun Hee; 
  • ... Jang, Ja-Hyun; 
  • 외 5명
Citations

WEB OF SCIENCE

8
Citations

SCOPUS

7

초록

Background The genetic features and treatment strategies of lateralized overgrowth have been elusive. We performed this study to analyze the genetic characteristics and treatment results of propranolol- or alpelisib-treated patients with lateralized overgrowth. Methods Fifteen patients with lateralized overgrowth were involved. Clinical characteristics and whole-body magnetic resonance imaging (WB-MRI) findings were evaluated. Targeted exome sequencing with a gene panel of affected tissue and peripheral white blood cells was performed. Propranolol was administered and treatment results were evaluated. The PIK3CA inhibitor alpelisib was prescribed via a managed access program. Results The identified mutations were PIK3CA (n = 7), KRAS (n = 2), PTEN (n = 1), MAP2K3 (n = 1), GNAQ (n = 1), TBC1D4 (n = 1), and TEK (n = 1). Propranolol was prescribed in 12 patients, and 7 experienced mild improvement of symptoms. Alpelisib was prescribed in two patients with a PIK3CA mutation, and the reduction of proliferated masses after 1 year of treatment was proved by WB-MRI. Conclusions Targeted exome sequencing identified various genetic features of lateralized overgrowth. Propranolol could be applied as an adjuvant therapy for reducing vascular symptoms, but a PIK3CA inhibitor would be the primary therapeutic strategy for PIK3CA-related overgrowth syndrome.

키워드

PIK3CA-related segmental overgrowth syndrome; Lateralized overgrowth; Alpelisib; Targeted exome sequencing; INFANTILE HEMANGIOMA; SPECTRUM PROS; MUTATION; AS160; DIAGNOSIS; NEVUS
제목
Clinical and genetic analyses of patients with lateralized overgrowth
저자
Kim, Yoon-Myung; Lee, Yena; Choi, Yunha; Choi, In Hee; Heo, Sun Hee; Choi, Jung Min; Do, Hyo-Sang; Jang, Ja-Hyun; Yum, Mi-Sun; Yoo, Han-Wook; Lee, Beom Hee
DOI
10.1186/s12920-022-01362-1
발행일
2022-09-30
유형
Article
저널명
BMC Medical Genomics
권
15
호
1